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Summary
Here, we identify fetal bone marrow (BM)-derived
CD34hiCD45RAhiCD7+ hematopoietic progenitors as
thymus-colonizing cells. This population, virtually ab-
sent from the fetal liver (FL), emerges in the BM by de-
velopment weeks 8–9, where it accumulates through-
out the second trimester, to finally decline around
birth. Based on phenotypic, molecular, and functional
criteria, we demonstrate that CD34hiCD45RAhiCD7+
cells represent the direct precursors of the most imma-
ture CD34hiCD1a2 fetal thymocytes that follow a simi-
lar dynamics pattern during fetal and early postnatal
development. Histological analysis of fetal thymuses
further reveals that early immigrants predominantly
localize in the perivascular areas of the cortex, where
they form a lymphostromal complex with thymic epi-
thelial cells (TECs) driving their rapid specification
toward the T lineage. Finally, using an ex vivo xenoge-
neic thymus-colonization assay, we show that BM-
derived CD34hiCD45RAhiCD7+ progenitors are selec-
tively recruited into the thymus parenchyma in the
absence of exogenous cytokines, where they adopt
a definitive T cell fate.
*Correspondence: bruno.canque@paris7.jussieu.frIntroduction
During human fetal ontogeny, the thymus rudiment de-
velops from the third pharyngeal pouch at gestation
weeks 4–5 and starts to be colonized by blood-borne
hematopoietic progenitor cells (HPCs) by weeks 8–9
(Campana et al., 1989; Haynes and Heinly, 1995; Haynes
et al., 1988a; Lobach et al., 1985). Hence, mature T lym-
phocytes (TL) expressing either a/b or g/d T cell recep-
tors (TCR) are first detected in the thymus parenchyma
about 1 week later. Thymus corticomedullary partition-
ing occurs later on, by week 14, and the definitive thy-
mus architecture is established by gestation week 16
(Haar, 1974; Norris, 1938; von Gaudecker and Muller-
Hermelink, 1979). It is now recognized that colonization
of the murine fetal thymus is ensured by already T-line-
age-specified progenitors, the initial recruitment of
which involves interactions of chemokine receptors
CCR7 and CCR9 with their respective CCL21 and
CCL25 ligands (Benz and Bleul, 2005; Douagi et al.,
2002; Katsura, 2002; Liu et al., 2005). In contrast, the
identity of human thymic progenitors remains elusive,
and whether they actually correspond to multipotent
HPCs, to common lymphoid progenitors (CLPs), or to
progenitors committed to the T lineage is still conten-
tious (Blom et al., 1998; Spits, 2002). Early reports,
based on immunohistology, proposing that the fetal thy-
mus is seeded by fetal liver (FL)-derived CD7-express-
ing TL precursors have never been confirmed (Haynes
et al., 1988a, 1988b, 1989). Instead, there is strong evi-
dence that the human FL actually lacks TL progenitor
activity (Barcena et al., 1993; Sanchez et al., 1993), and it
is now established that, unlike in the mouse, the capac-
ity of FL progenitors to develop into TL is constrained
to the most immature multipotent CD34+CD382 HPC
subset (Blom et al., 1997; Jaleco et al., 1997). The hy-
pothesis that human thymic precursors emerge in the
fetal bone marrow (BM) was also considered about
10 years ago, leading to the identification of two minor
CD34+Lin2CD10+ and CD34+CD7+CD2+ populations of
candidate thymus-colonizing cells (Galy et al., 1995; Ter-
stappen et al., 1992). There is now evidence that umbil-
ical cord blood (UCB) CD34+Lin2CD10+ HPCs display
predominant B lymphocyte (BL) differentiation potential
(Haddad et al., 2004), whereas it remains unclear
whether CD34+CD7+CD2+ HPCs actually correspond
to TL precursors.
As no extrathymic population of candidate TL precur-
sors has been identified so far, it is assumed that the fe-
tal thymus is passively seeded by multipotent liver-de-
rived hematopoietic stem cells (HSCs) (Rothenberg
and Taghon, 2005; Spits, 2002). Yet, analysis of the
CD34+CD1a2 fetal thymocyte population failed to detect
precursors with antigen expression pattern or differenti-
ation potential suggestive of pluripotent HSCs but in-
stead led to the identification of a minor subset of al-
ready T-lineage-specified CD34hi precursors that was
no longer found in the postnatal thymus (Barcena
et al., 1993; Terstappen et al., 1992). The most immature
CD34hiCD1a2 thymocytes express intracytoplasmic
Immunity
218
Characterization of Human Fetal Prethymocytes
219CD3 as well as cell surface CD2, CD5, and CD7 and dis-
play strong T and NK cell potentials while retaining only
a marginal capacity to generate granulomacrophagic
colonies (Barcena et al., 1994; Galy et al., 1993a; San-
chez et al., 1993). Thus, although one cannot rule out
the possibility that HSCs enter the TL differentiation
pathway as soon as they gain access to the thymus pa-
renchyma, these reports suggest that colonization of the
thymus could actually be ensured by a still-uncharacter-
ized population of precursors (Rossi et al., 2005;
Schwarz and Bhandoola, 2004).
We have identified a population of UCB CD34hi
CD45RAhiCD7+ HPCs that comprises clonal bipotent
NK and dendritic cell (DC) progenitors and shares with
CD34+CD1a2 thymocytes the capacity to differentiate
into Langerhans cells via a TGF-b1-independent path-
way (Canque et al., 2000). Combining clonal analysis of
lymphoid potential and microarray transcriptional profil-
ing, we have shown that these CD34hiCD45RAhiCD7+
HPCs already express germline TCRg transcripts and
correspond to progenitors polarized toward the T/NK
lineage (Haddad et al., 2004). Here, we investigated the
biological function of this population, seeking its possi-
ble contribution to the ontogeny of the T lineage. To cir-
cumvent the limitations inherent to most in vitro studies
of human HPCs, we devised a developmental approach
based on in vivo tracking of the CD34hiCD45RAhiCD7+
HPCs in developing fetuses. We found that this popula-
tion emerges in the fetal BM as early as gestation weeks
8–9, accumulates in the BM throughout the second
trimester, and drastically decreases at the end of gesta-
tion. Combining phenotypic, functional, and develop-
mental criteria, we also demonstrate that they represent
the direct precursors of the most immature fetal
CD34hiCD1a2 thymocytes and display strong T cell dif-
ferentiation potential and a unique capacity to respond
to ‘‘thymus attraction’’ (Le Douarin et al., 1984).
Based on these findings, we propose that CD34hi
CD45RAhiCD7+ HPCs represent the long-sought human-
thymus-colonizing cells and should thus be considered
as the fetal prethymocytes.
Results
CD34hiCD45RAhiCD7+ HPCs Are Absent from
the FL Prior to the Onset of BM Hematopoiesis
As a first step toward the functional characterization of
CD34hiCD45RAhiCD7+ HPCs, we searched for the intra-
embryonic site from which they emerge. Because early
hematopoiesis takes place in the FL between weeks 6
and 24 (Peault and Tavian, 2003), we first investigated
whether cells with the corresponding phenotype could
be detected among FL CD34+ HPCs by weeks 6–10. Be-
cause this period precedes (see Figures S1A and S1B inthe Supplemental Data available with this article online)
or coincides (Figure S1C) with the onset of BM hemato-
poiesis (Charbord et al., 1996), one might assume that
detecting CD34hiCD45RAhiCD7+ HPCs there would indi-
cate their intrahepatic origin. Flow cytometry analysis of
FL mononuclear cells (MNCs) obtained during this pe-
riod showed that, according to CD34 expression levels
and forward scatter (FSC) characteristics, FL CD34+
cells segregated into two CD34hiFSChi and CD34intFSClo
subsets (referred to as R1 and R2) accounting for 65%6
3% and 35% 6 3% of the FL CD34+ HSCs, respectively
(n = 5). Labeling with CD45RA-phycoerythrin (PE) and
CD7-fluorescein isothiocyanate (FITC) monoclonal anti-
bodies (mAbs) did not disclose the presence of CD34hi
CD45RAhiCD7+ cells among either subset. As reported
(Barcena et al., 1993; Phillips et al., 1992), CD7 expres-
sion by FL MNCs was restricted to CD342CD56+ NK
cells that represented about 5% of the cells (data not
shown). Also consistent with reports that the early FL
provides a permissive environment for BL differentiation
(Abe, 1989; Hofman et al., 1984), we found that the
CD34intFSClo cell subset comprised a majority of
CD10+CD19+ BL progenitors. Analysis of MNCs from
FLs obtained later on, between gestation weeks 10 and
20, detected %3% CD34hiCD45RAhiCD7+ cells among
CD34hiFSChi cells, but, because BM hematopoieisis is al-
ready ongoing at this stage, one cannot rule out that
these cells actually correspond to progenitors of extra-
hepatic origin circulating in the fetal blood.
These data show that, as suggested (Barcena et al.,
1993; Blom et al., 1997; Jaleco et al., 1997), the early
human FL lacks CD34+CD7+ TL progenitors.
The Fetal BM Is a Primary Site for the Emergence
of CD34hiCD45RAhiCD7+ HPCs
We next examined whether CD34hiCD45RAhiCD7+ HPCs
actually emerged in the fetal BM. Flow cytometry analy-
sis of 26 BM samples from gestation weeks 8–32
showed that, in contrast to the FL, cells coexpressing
CD45RA and CD7 are detected at the very onset of BM
colonization by FL-derived HSCs (Figure 1A). By weeks
8–9, CD34hiCD45RAhiCD7+ HPCs already account for
13% 6 5% of the CD34+ HPCs (median, 14%; range,
5%–20%; n = 4). From week 10 onward, BM CD34+ HPCs
segregate into two major populations of CD34hiFSChi
(R1) and CD34intFSClo (R2) cells, the latter being highly
enriched in CD10+CD19+ BL progenitors (Figure 1B
and data not shown). CD34hiCD45RAhiCD7+ HPCs pro-
gressively accumulate in the BM to reach peak levels at
weeks 15–20, representing then 27% 6 12% of CD34hi
FSChi HPCs (median, 29%; range, 7%–51%; n = 13) (Fig-
ures 1C and 1D). At that time, the previously charac-
terized CD34hiCD45RAhiLin2CD10+ progenitors (Galy
et al., 1995; Haddad et al., 2004) represent 19% 6 11%Figure 1. Kinetics of CD45RAhiCD7+ HPCs in Fetal and Postnatal BM
(A and B) Detection of CD34+CD45RAhiCD7+ HPCs in gestation weeks (A) 8 and (B) 13 BMs: gates were set based on CD34 expression levels and
FSC characteristics (see legend of Figure 1); note that BM MNCs before gestation week 10 contain a unique population of CD34hi/intFSChi cells.
Data are presented as dot plots, and percentages of specifically labeled cells are indicated.
(C and D) Kinetics of CD34+CD45RAhiCD7+ HPC percentages in the BM from gestation weeks 8–9 to 50 years postnatal: MNCs were labeled with
CD34, CD45RA, CD7, and CD10 mAbs; gates were set on CD34hi/intFSChi cells (R1); data are presented as (C) dot plots or (D) a scatter graph of
specifically labeled cells in which median values are indicated (bars).
(E) Kinetics of BM CD34hiCD45RAhiCD7+CD10+ HPC percentages during development: BM MNCs were labeled, FACS analyzed, and plotted as
in Figure 2C.
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220of the CD34hiFSChi HPCs (median, 27%; range, 2%–
33%; n = 9), indicating that early lymphoid progenitors
account for as much as 45%6 22% of BM CD34hiFSChi
HPCs during development second trimester. Of note
here, we identified by quadruple labeling CD34hi
CD45RAhiLin2CD10+ HPCs as being actually also
CD192, but, to avoid any confusion, we kept its original
Lin2 designation (Galy et al., 1995). Later on, during the
last trimester, BM CD34hiCD45RAhiCD7+ HPC percent-
ages decline to levels comparable to those observed
in the UCB (Haddad et al., 2004). Analysis of a series of
30 postnatal BM samples from 1- to 50-year-old donors
confirmed these findings, since only few CD34hi
CD45RAhiCD7+ cells are detected in the BM beyond 5
years of age (3% 6 2% of CD34hiFSChi cells; median,
2%; range, 1%–10%; n = 26). Parallel analysis showed
that, overall, the CD34hiCD45RAhiLin2CD10+ HPC popu-
lation follows a development kinetics similar to that
of the CD34hiCD45RAhiCD7+ HPCs, except that they
persist to significantly higher levels during postnatal
life (Figure S2). Because of reports of the presence
of CD7+CD10+ cells among CD34+ HPCs (Galy et al.,
1995; Haddad et al., 2004; Rossi et al., 2003), we also ex-
amined the kinetics of CD7 and CD10 expression by BM
CD34hiFSChiCD45RAhi HPCs from gestation week 16 to
32 years postnatal (Figure 1E). Consistent with our re-
port that CD34hiCD45RAhiCD7+ and CD34hiCD45RAhi
Lin2CD10+ HPC populations overlap but marginally
(Haddad et al., 2004), we found that only a minority of
the cells coexpressed both markers. Hence, the
CD7+CD10+ cell fraction was not studied further.
We next verified that the differences reported above
between FL and BM regarding the capacity to support
the emergence of CD34hiCD45RAhiCD7+ HPCs actually
reflected intrinsic site specificities. FL and BM cells
were thus harvested from the same fetuses between
weeks 19 and 22 and compared as to the content in
CD34hiCD45RAhiCD7+ HPCs. As expected, CD34hi
CD45RAhiCD7+ HPC percentages were 10- to 40-fold
greater in the BM than in the FL, which confirms that
the BM is the major site where they differentiate (Fig-
ure S3A). Moreover, because the human fetal spleen
lacks hematopoietic activity, it may be assumed that de-
tecting these HPCs at this level should provide an indi-
rect means to examine whether they access the fetal cir-
culation. Analysis of splenocytes obtained at gestation
weeks 13 and 20 showed similar CD34hiCD45RAhiCD7+
HPC levels than among FL MNCs, suggesting that a sub-
stantial fraction of BM-derived CD34hiCD45RAhiCD7+
HPCs actually transits via the fetal blood (Figure S3B).
Phenotypic and Functional Characterization of Fetal
BM CD34hiCD45RAhiCD7+ HPCs
Extensive phenotypic characterization of fetal BM
CD34hiFSChiCD45RAhi HPCs showed that CD7+102 cells
expressed low to intermediate CD38 and CD33, whereas
CD7210+ cells were preferentially CD127/IL-7R+ (Fig-
ure 2A, upper left panel). Interestingly, 20%–35%
CD7+102cells also expressed low surface CD2 and intra-
cytoplasmic CD3, while lacking the CD5 TL marker
(Figure 2A, upper right panel). These data are consistent
with the report that fetal BM comprises a population of
CD34+CD7+CD2+ HPCs (Terstappen et al., 1992). About
one third ofCD7+CD102cells expressed CXCR4 or CCR9(Figure 2A, lower panel), the CCL25 receptor known to
play a role in thymus colonization (Liu et al., 2005).
CD34hiCD45RAhiCD7+ HPCs also strongly expressed
CD117 and lacked CD135 and CD27 (Figure 2B). These
data are consistent with the reports that the murine
thymus-repopulating activity is largely constrained to
Lin2CD25-CD117+CCR9+ BM cells (Benz and Bleul,
2005; Schwarz and Bhandoola, 2004). Of note, none of
the CD34+ BM HPC populations expressed regulatory
TL transcription factor Foxp3 (data not shown).
We next performed a side-by-side analysis of the
in vitro differentiation potentials along the erythroid, gra-
nulomonocytic, or lymphoid lineages of sorted fetal BM
CD34hiCD45RAhiCD7+ and CD34hiCD45RAhiLin2CD10+
HPCs. Semisolid assays confirmed that, like their
UCB homologs (Haddad et al., 2004), fetal CD34hi
CD45RAhiCD7+ HPCs retain the capacity to generate
granulomacrophage colonies, whereas their CD45RAhi
Lin2CD10+ homologs generate only rare macrophage
colonies (<1/500 cells seeded) (Table 1). These popula-
tions were then tested for the capacity to generate
NK cells or BLs (Figures 2C and 2D). Gestation week
22 BM CD34hiCD45RAhiCD7+ and CD34hiCD45RAhi
Lin2CD10+ HPCs were thus sorted and cultured under
conditions to generate either NK cells or BLs (see Sup-
plemental Experimental Procedures). After 2 week cul-
ture of CD34hiCD45RAhiCD7+ HPCs under the ‘‘NK con-
dition,’’ CD56+ NK cell percentages reached up to 95%,
versus %5% with CD34hiCD45RAhiLin2CD10+ HPCs.
Due to limited expansion, only 1–2 3 103 NK cells per
103 cells seeded were recovered from CD34hiCD45RAhi
Lin2CD10+ HPC cultures relative to 250–500 greater
yields with CD34hiCD45RAhiCD7+ HPCs. Culture under
the ‘‘B condition’’ showed that both populations gener-
atedR90% CD19+ BLs, but, due to greater expansion,
CD34hiCD45RAhiLin2CD10+ HPC cultures comprised
approximately 5-fold greater absolute numbers of
CD19+ BLs. That similar findings were obtained with
week 13 BM cells (data not shown) stresses the rele-
vance of these results. Murine fetal thymus organ
cultures (FTOCs) were then used to assess the T poten-
tial of CD34hiCD45RAhiCD7+ and CD34hiCD45RAhi
Lin2CD10+ HPCs (Figure 2E). As expected from our pre-
vious results with UCB cells (Haddad et al., 2004), when
seeding alymphoid thymus lobes with 0.5 3 104 cells,
only the CD34hiCD45RAhiCD7+ cells displayed a sub-
stantial capacity to differentiate into TLs: after 4 weeks,
about 10-fold more CD45+ cells were recovered from
lobes seeded with CD34hiCD45RAhiCD7+ HPCs, with
70%–80% CD4+CD8+ double-positive (DP) thymocytes,
half of which coexpressed low to intermediate TCRab
levels. In contrast, only rare CD4+CD8+ DP thymocytes
were recovered from cultures initiated with CD34hi
CD45RAhiLin2CD10+ HPCs, and they comprised a
majority of immature single-positive (ISP) CD4int cells.
These data demonstrate that, like their UCB homologs
(Haddad et al., 2004), fetal BM CD34hiCD45RAhiCD7+
HPCs display a stronger NK cell than BL potential and
are enriched in TL progenitors.
BM CD34hiCD45RAhiCD7+ HPCs Are Direct
Precursors of CD34hiCD1a2 Fetal Thymocytes
We then reasoned that, if CD34hiCD45RAhiCD7+ HPCs
are colonizing the fetal thymus, we should detect them
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221Figure 2. Phenotype and Lymphoid Potential of Fetal BM CD45RAhiCD7+ HPCs
(A and B) Phenotyping of CD45RAhiCD7+ HPCs: gates were set on CD34hi/intFSChiCD45RAhi cells and (A) lineage-affiliated markers and chemo-
kine receptors, and (B) growth factor and TNF family receptors were analyzed; percentages of specifically labeled cells are indicated; the data are
composite results from (A) two gestation week 15 and 17 BMs and (B) a gestation week 17 BM.
(C and D) Assessment of NK cell and BL differentiation potentials of CD45RAhiCD7+ and CD45RAhiLin2CD10+ HPCs: cells were sorted from a ges-
tation week 22 fetal BM and cultured for 14 days onto MS5 cells with either (C) SCF, Flt-3L, IL-2, IL-7, and IL-15 (NK condition) or (D) SCF, throm-
bopoietin (TPO), and IL-7 (B condition). At the end of the culture, cells were labeled with CD56-PE and CD19-FITC mAbs and FACS analyzed.
Percentages (left panels) and absolute numbers (right panel) of specifically labeled cells are indicated; data are from one of two experiments.
(E) FTOC assay: sorted CD45RAhiCD7+ and CD45RAhiLin2CD10+ HPCs (0.5 3 104 cells/lobe) from pooled gestation week 15 and 19 BM MNCs
were cultured for 48 hr in hanging drops with SCF, IL-2, and IL-7; lobes were then transferred onto floating nucleopore filters and cultured for 4
weeks; cells recovered from the lobe were labeled with CD45, CD4, CD8, and TCRa/b mAbs; FACs analysis was performed on CD45+ human
cells; percentages and absolute numbers of specifically labeled cells are indicated; data are from one of two experiments.among the most immature thymic populations. CD34+
CD1a2/+ cells from 15 to 16 week fetal thymuses were
thus extensively analyzed. Because this population rep-
resents 0.1%–0.2% of thymocytes, acquisition gates
were restricted to cells with a CD34 mean fluorescence
intensity (MFI) R10 arbitrary units (AU). We thus found
that CD34+ thymocytes segregated into two populations
of ‘‘large’’ FSChiSSChi (R1) and ‘‘small’’ FSCloSSClo (R2)
cells, the latter corresponding essentially to already
T-lineage-committed CD34dimCD1a+ precursors (Fig-
ure 3A). Therefore, only large FSChiSSChi R1 thymocytes
were further considered. Based on CD34 expression,
the CD1a2 fraction could subsequently be divided into
three subsets: CD34hiCD1a2 (A, MFIR103 AU), CD34int
CD1a2 (B, 102 %MFI %103 AU), and CD34dimCD1a2
(C, 101%MFI%102 AU). CD34hiCD1a2 thymocytes (sub-
set A), assumed to be the most immature (Barcena et al.,
1993; Res et al., 1996), expressed CD45RA and CD7 and
no or low CD10 and CD38 (Figure 3B and data not
shown). At no time point, even at the very onset of
thymus colonization by gestation weeks 9–11, were thy-
mic CD34hiCD382CD72 cells detected (data not shown),which confirms that the fetal thymus lacks immature
HSCs (Barcena et al., 1993; Res et al., 1996; Terstappen
et al., 1992). Moreover, like fetal BM CD34hiCD45RAhi
CD7+ HPCs, the CD34hiCD1a2 thymocytes expressed
myeloid lineage-affiliated marker CD33 but lacked
CD127/IL-7R, the latter being detected on CD34int
CD1a2 cells (subset B). Nonetheless, the majority of
CD34hiCD1a2 thymocytes also expressed surface CD2
and CD5 as well as cytoplasmic CD3, which is indicative
of specification toward the T/NK lineage. Consistent
with these findings, a significant fraction of these cells
expressed the CXCR4 chemokine receptor, whereas
CCR5 and CCR7 expression was only noted on
CD34intCD1a2 and CD34dimCD1a2 thymocytes (Fig-
ure 3C). At variance with BM CD34hiCD45RAhiCD7+
HPCs, CD34hiCD1a2 thymocytes expressed only low
CCR9 and CD117 levels.
To further assess the relationship of BM CD34hi
CD45RAhiCD7+ HPCs with CD34hiCD1a2 thymocytes,
we next examined the dynamics pattern of CD34hi
CD1a2 thymocytes during fetal and early postnatal
development. CD34/CD1a colabeling of 25 fetal and
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months postnatal, disclosed a complex thymus matura-
tion process (Figure 3D). Based on the evolution of the
large (R1) and small (R2) CD34+ thymocytes, as well as
on CD34 and CD1a expression levels, four thymus de-
velopment stages could be identified. Stage I extends
from the onset of thymus colonization, by gestation
weeks 8–9, to week 13. At that time, the R1 subset ac-
counts for R70% of CD34+ thymocytes, most of which
are CD1a2. Stage II encompasses gestation weeks 14–
16 and coincides with the establishment of corticomed-
ullary partitioning (Haar, 1974; Norris, 1938; von Gau-
decker and Muller-Hermelink, 1979); it is associated
with the rapid accumulation of small CD34dimCD1a+ R2
thymocytes. Stage III extends from gestation week 18
to 4 months postnatal and is characterized by the per-
sistence of a population of large CD34hiCD1a2 immature
thymocytes as well as by appearance of intermediate
CD34intCD1a+ cells with mixed R1 and R2 scatter char-
acteristics; by 4 months of age, small R2 cells account
for R75% of CD34+ thymocytes. Stage IV begins by
5 months of age when the frequency of large CD34hi
CD1a2 thymocytes markedly declines and CD34int/dim
CD1a2/+ thymocytes adopt a definitive postnatal pheno-
typic profile. Interestingly, CD34hiCD1a2 cell percent-
ages among the large R2 thymocytes remain stable
from gestation week 9 to 4 months postnatal (stages
I–III; median, 8%; range, 1%–17%; n = 23) and progres-
sively drop to negligible levels thereafter (Figure S4).
We next analyzed by conventional RT-PCR the ex-
pression of a variety of granulomacrophagic, B- and T-
lineage-affiliated markers in fetal CD34hiCD1a2CD1272
and CD34intCD1a2CD127+ thymocytes as compared
with CD34intCD1a2 and CD34dimCD1a+ thymocytes
from donors beyond 1 year of age (Figures 4A–4D).
Only the CD34hiCD1a2CD1272 thymocytes were found
to retain expression of the myeloid lineage-affiliated
gene MPO and to already display germline TRGV9 tran-
scripts, stressing their ontogenetic link with BM
CD34hiCD45RAhiCD7+ precursors (Haddad et al., 2004).
CD34intCD1a2CD127+ thymocytes, which represent
the immediate downstream progeny of the formers, ex-
pressed E2A and LEF-1 transcription factors but still
lacked GATA3 and PTCRA transcripts, arguing thus for
a stepwise specification toward the T lineage. As ex-
pected, CD34intCD1a2 postnatal thymocytes already
expressed LEF1 andGATA3 as well as PTCRA, whereas
Table 1. Assessment of the Erythroid and Granulomacrophagic
Potential of Fetal BM HPC Populationsa
CD34+ HPC Populations
CD45RAhiCD7+ CD45RAhiCD10+
Experiment
#1
Experiment
#2
Experiment
#1
Experiment
#2
BFU-E 0b 0 0 0
CFU-G/GM 11 14 1 0
CFU-M 21 24 0 1
a Results are from two independent experiments performed with
gestation week 13 or 19 BM cells.
b Numbers of erythroid-burst-forming units (BFU-E), granulocyte
(CFU-G/GM), and macrophage (CFU-M) colony-forming units per
500 cells seeded.RAG1 andRAG2 transcripts were mainly detected at the
subsequent CD34dimCD1alo/+ stage. Germline TRGV9
sterile transcripts were no longer detected beyond that
stage (Figure 4E).
Fetal CD34hiCD1a2 and CD34intCD1a2CD127+ thy-
mocytes were finally tested for their in vitro differentia-
tion potentials (Figures 4F–4H). Both populations lacked
granulomacrophagic potential (<1 CFU-GM/M per 100
cells) but had a strong capacity to generate NK cells.
However, they markedly differed with respect to their
B potential, since only the most immature CD34hi
CD1a2CD1272 cell population generated BLs, albeit
with reduced efficiency. Whether CD34intCD1a2CD127+
thymocytes retained some capacity to generate DCs
was also examined: after 8-day culture under appropri-
ate conditions (see Supplemental Experimental Proce-
dures), >80% of nonadherent cells corresponded to pro-
totypic CD1a+HLA-DR+ DCs with the proper light scatter
characteristics. Interestingly, about 50% of these also
stained positive for CD207/Langerin, indicating that
they actually corresponded to Langerhans cells (Can-
que et al., 2000; Dalloul et al., 1999).
Altogether, these data support the idea that BM
CD34hiCD45RAhiCD7+ HPCs are the direct ontogenetic
precursors of CD34hiCD1a2 thymocytes.
Early Thymus Immigrants Form a Lymphostromal
Complex with Thymic Epithelial Cell Dendritic
Processes
The finding that the most immature CD34hiCD1a2 fetal
thymocytes had already entered the T pathway prompted
us to investigate their subanatomic localization. Analysis
of development weeks 10–16 thymuses first confirmed
that cortical-medullar partitioning actually occurs by
gestation week 13 (Haar, 1974; Lobach et al., 1985) and
showed the broadly bifocal distribution of blood vessels
both at the outer surface of the external cortex and in the
inner cortical zone up to the corticomedullar junction
(Figure S5). Since most thymocytes express CD7 and
CD45RA, two-color immunofluorescence analysis with
CD34/CD1a and CD34/F8VWF (factor VIII-Von Wille-
brand factor) mAbs was performed on thymic serial
sections to identify the most immature subset. CD34+
CD1a2/CD34+FVWF2 thymocytes were found at low
density, scattered from the immediate subcortical zone
to the deep corticomedullar junction, in the vicinity of
blood vessels resembling postcapillary veinules (Figures
5A and 5B, upper panels) (Lind et al., 2001; Raviola and
Karnovsky, 1972). Analysis at higher magnification con-
firmed that CD34+CD1a2/CD34+FVWF2 immigrants pre-
ferentially localize in CD1a2 perivascular zones that are
enriched in cytokeratin+ TECs with typical stellate mor-
phology (Figures 5A and 5B, lower right panels) and
disclosed the spatial proximity between CD34 and cyto-
keratin labeling. Inasmuch as it is known that in vitro-
cultured human TECs may coexpress both markers
(Galy et al., 1993b), we examined whether they colocal-
ized within the same thymic cells. Three-dimensional
reconstruction of serial optical confocal microscopy
sections of CD34+ cells failed to disclose any colocaliza-
tion of the markers but, instead, showed that the
dendritic-like cytokeratin+ projections form structures
resembling a lymphostromal synapse with CD34+ thy-
mocytes (Figure 5C). In addition, stellate-like TEC bodies
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(A–C) Phenotyping of CD34+CD1a2/+ fetal thymocytes. (A) Gating procedure for phenotyping of CD34+CD1a2 thymocytes: cells were triple la-
beled with CD34, CD1a, and the indicated mAbs; acquisition gates were set on cells with CD34+ MFIR10 AU, which led to distinguish a large
FSChiSSChi (R1, red) and a small FSCloSSClo (R2, green) population; R1 cells were divided into three subsets according to CD34 expression
levels: CD34hi (A, MFIR103 AU), CD34int (B, 102%MFI%103 AU), and CD34dim (C, 101%MFI%102 AU). (B) Phenotyping of and (C) expression
of chemokine and growth factor receptors by cells of the R1 subset: relative percentages of CD34hiCD1a, CD34intCD1a2, and CD34dimCD1a2
cells are indicated. Note that use of PE- or allophycocyanin (APC)-conjugated CD34 mAbs slightly modifies the repartition of the populations.
The length of the lower short bars corresponds to the extent of the fluorescence intensity of negative controls. Data are from gestation week
(A and B) 15 and (C) 16 thymuses.
(D) Evolution of a large R1 (red) and a small R2 (green) CD34+ thymocytes during the fetal and postnatal life. Percentages of CD34hiCD1a2 thy-
mocytes (subset A) and major phenotypic changes are indicated (blue arrows).were always CD34 negative, stressing thus the validity of
the data (data not shown).
These findings strongly argue for multifocal thymus
seeding during fetal development (Kyewski, 1987; Le
Douarin et al., 1984) and show that the earliest thymus
immigrants establish tight interactions with TEC pro-
cesses that most probably drive their rapid specification
toward the T lineage.
CD34hiCD45RAhiCD7+ HPCs Are Selectively
Recruited into the Thymus in Ex Vivo Colonization
Assays
Since the above results strongly suggested that BM-
derived CD34hiCD45RAhiCD7+ HPCs correspond to thy-
mus-colonizing cells, we reasoned that, if so, they should
respond to thymus attraction as proposed by Le Douarin
et al. some 20 years ago (Le Douarin et al., 1984). To test
this hypothesis, we designed an ex vivo thymus coloni-
zation assay mimicking the earliest stages of fetal thy-
mus colonization, which is assumed to occur before
establishment of the thymic vasculature (Dunon et al.,1993; Liu et al., 2005; Suniara et al., 1999), and used 5-
(and-6)-carboxyfluorescein diacetate succinimidyl ester
(CFSE) fluorochrome tracking to compare the capacity of
CD34hiCD45RAhiCD7+ and CD34+CD45RAintLin2 HPCs
to enter alymphoid thymus lobes from NOD/SCID mouse
embryos. CD34hiCD45RAintLin2HPCs have been shown
to display mixed granulomonocytic and lymphoid poten-
tial and, at the ontogenetic level, to correspond to up-
stream precursors of CD34hiCD45RAhiCD7+ cells (Had-
dad et al., 2004). Thymic lobes were analyzed after
a short 48 hr culture in order to rule out the possible post-
entry selection of the cells. Conventional one-photon
fluorescence microscopy showed the massive infiltra-
tion of lobes seeded with CD34hiCD45RAhiCD7+ HPCs,
whereas only rare CFSE+ cells were detected at the pe-
riphery of CD34+CD45RAintLin2HPC-seeded lobes (Fig-
ure 6A). To confirm that CD34hiCD45RAhiCD7+ HPCs
entered the thymus parenchyma, lobes were subse-
quently analyzed by two-photon confocal microscopy
and three-dimensional reconstructions of serial optical
sections, which showed indeed that most CFSE+ cells
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224Figure 4. Molecular Characterization and In Vitro Differentiation Potential of CD34hiCD1a2CD1272 and CD34intCD1a2CD127+ Fetal Thymocytes
CD34+ cells from gestation weeks (A) 17–19 or (B) 16–24 months postnatal thymuses, or (C) from the UCB, were sorted into populations of the
indicated phenotypes. The sorting gates were set on large FSChiSSChiCD34+CD1a2 fetal thymocytes or total CD34int/lo postnatal thymocytes.
(D) RT-PCR analysis of fetal (lanes 1 and 2) and postnatal (lanes 3 and 4) CD34+ thymocytes, and CD34+CD45RAintLin2 or CD34+CD45RAhiCD7+
UCB HPCs (lanes 5 and 6); data are representative of two PCR amplifications performed on two independently prepared cDNA samples.
(E) RT-PCR analysis of TRGV9 expression in sorted CD34dimCD1a2 (Ea), CD34loCD1a+ (Eb), CD342CD1a+CD4loCD82 ISP (Ec), CD4+CD8+ DP
(Ed), and CD4+/2CD82/2TCRa/b+ single-positive thymocytes (Ee and Ef) from postnatal thymuses beyond 1 year of age.
(F and H) Large CD34+CD1a2 thymocytes from gestation weeks 15 or 18 thymuses were sorted into CD34hiCD1a2CD1272 and CD34int
CD1a2CD127+ populations as described in Figure 3. Cultures under the (F) NK and (G) B conditions were conducted as described in the legend
of Figure 2. (H) Cultures under the DC condition were conducted for 8 days with SCF, Flt3L, GM-CSF, and TNF-a before FACS analysis. Percent-
ages (left panels) and absolute numbers (right panel) of specifically labeled cells are indicated. Data are from one of two experiments.actually crossed the basement membrane to localize in-
side the thymus parenchyma (Figure 6B). Consistent
with these findings, expression of G protein-associated
receptors CD97, CXCR4, and CCR9 was restricted to
the CD34hiCD45RAhiCD7+ HPC subset (Figure S6).
To further investigate the relationship between thy-
mus colonization and TL differentiation, we next exam-
ined whether exogenously added cytokines affected
CD34hiCD45RAintCD72 HPC entry into alymphoid thy-
mus lobes. CFSE-labeled CD34hiCD45RAintCD72 cells
were cultured as before in hanging drops with or without
stem cell factor (SCF), interleukin (IL)-2 and IL-7, a cock-
tail routinely used in FTOC assays (see Supplemental
Experimental Procedures). Analysis by one-photon fluo-
rescence microscopy 48 hr later confirmed that the cells
did not spontaneously enter the thymus lobes or adhere
to the thymic capsule (Figure 6C, right panel). In con-
trast, the cells did infiltrate the thymus lobes when the
cytokines were added, indicating that, once activated,
they acquire some capacity to invade the thymic paren-
chyma or that the cytokines are necessary for their sur-
vival or proliferation. Therefore, we next examined
whether cytokine-activated CD34hiCD45RAintLin2 cells
also adopted an intrathymic TL fate. To this end,
their T potential was compared with that of CD34hi
CD45RAhiCD7+ HPCs in FTOC assays, which were initi-ated as before under limiting conditions using 0.5 3 104
cells per lobe. As expected, only the CD34hiCD45RAhi
CD7+ HPCs could generate CD4+CD8+ DP TLs within
2 weeks (Figure 7A, upper panel). By culture week 4,
TCRa/b+ single-positive CD4+ TL percentages reached
98% of CD45+ human cells in CD34hiCD45RAhiCD7+
HPC-seeded lobes relative to %2% in cultures of
CD34hiCD45RAintLin2 HPCs, in which 40%–60% of
CD45+ cells were CD4+CD82TCRa/b2 ISP cells (Fig-
ure 7A, lower panel). Consistent with these findings,
after 4 week culture, 60- to 86-fold more CD45+ human
cells were recovered from lobes seeded with CD34hi
CD45RAhiCD7+ cells. That total nonfractionated CD34+
HPCs also displayed a limited TL potential, with 85-
fold less CD45+ human cells and%10% TCRa/b+ CD4+
TLs, confirms that the CD34hiCD45RAhiCD7+ population
is indeed enriched in TL progenitor activity.
Because we have shown that CD34hiCD45RAintLin2
HPCs are precursors of the CD34hiCD45RAhiCD7+
HPCs (Haddad et al., 2004), their T potential was further
studied in the OP9-DL1 coculture system (De Smedt
et al., 2004; La Motte-Mohs et al., 2005). In these cocul-
tures, an important fraction of the cells had acquired sur-
face CD7 by culture day 9 (Figure 7B), CD4+CD8+ DP TLs
being first detected by week 3 and reaching 18%–28% of
the cells 1 week later. At that time, CD3+ TCRg/d+ TLs
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225Figure 5. Subanatomic Localization of Early Thymus Immigrants
Low (upper panels, original magnification 633) and high (lower panels, original magnification 633, zoom 33) magnification views of gestation
weeks 14 and 16 thymus sections stained with CD34 (green) and CD1a, F8VWF or anticytokeratin mAbs (red), with DAPI nuclear counterstaining
(blue); CD34+CD1a2/F8VWF2 precursors predominantly localize in the vicinity of vessels from the (A) immediate subcortical zone to the (B) cor-
ticomedullar junction, where they closely associate with cytokeratin+ structures (right column); arrows indicate CD34+/CD1a2 or CD34+/VWF2
thymic immigrants. (C) Three-dimensional reconstructions of lymphostromal interactions: sections were stained with anti-CD34 (green) and
anti-cytokeratin (red) mAbs; serial optical sections at high magnification (original magnification: 633, zoom 33, z = 0.1 mm) followed by
three-dimensional projections are presented; insets represent original two-dimensional magnifications. Bars correspond to 10 mm.accounted for 1%–4% of the cells, whereas CD3+TCRa/
b+ TLs were detected only beyond culture day 35.
Altogether, these data indicate that BM-derived
CD34hiCD45RAhiCD7+ HPCs have a selective advantage
to enter the thymic structure in the absence of exoge-
nously added cytokines, where they adopt a definitive
TL fate.
Discussion
We have extensively analyzed the phenotype, develop-
mental potentials, dynamics, and gene expression pro-
file of diverse CD34+ populations from the UCB, the
postnatal BM, and thymus (Canque et al., 2000; Dalloul
et al., 1999; Haddad et al., 2004). Screening for alreadylymphoid-committed progenitors in the UCB led to the
identification of the CD34hiCD45RAhiCD7+ HPCs as to
a population that displays strong NK cell differentiation
potential and shares with postnatal thymocytes the
capacity to differentiate into Langerhans cells via
a TGFb-1-independent pathway (Canque et al., 2000).
On this basis, we raised the hypothesis that they could
correspond either to direct precursors of CD34+CD1a2
thymocytes or to CLPs. We addressed this issue by rea-
soning that, because candidate prethymocytes should
at least display a dual NK and T lymphoid potential,
probing the NK cell potential of CD34+ HPC populations
was a useful tool to screen for them. Therefore, we be-
gan by comparing their NK, B, granulomacrophagic,
and erythroid potentials with those of six other UCB
Immunity
226Figure 6. Ex Vivo Thymus Colonization Assay
(A) CD34+CD45RAhiCD7+ and CD34+CD45RAintLin2HPCs sorted from UCB were labeled with CFSE and cultured for 48 hr in hanging drops in the
absence of exogenously added cytokines before analysis by one-photon excitation confocal microscopy (original magnification 103).
Characterization of Human Fetal Prethymocytes
227Figure 7. T Potential of CD45RAhiCD7+ and CD34+CD45RAintLin2 HPCs in FTOC and in Culture with OP9-DL1 Cells
(A) FTOC assays: sorted UCB CD45RAhiCD7+ and CD34+CD45RAintLin2 HPCs were cultured with alymphoid NOD/SCID thymus lobes as de-
scribed in the legend of Figure 2. Cultures were maintained for 2 or 4 weeks before FACS analysis; percentages of specifically labeled cells
are indicated.
(B) OP9-DL1 cultures: sorted UCB CD34+CD45RAintLin2HPCs were cultured onto OP9-DL1 stromal cells with Flt-3L and IL-7 (see Supplemental
Experimental Procedures). FACS analysis was performed by weeks 2, 3, 4, and 5; OP9-DL1 cells were excluded from the analysis based on GFP
fluorescence; percentages of specifically labeled cells are indicated. The data presented are from one of two experiments.CD34+ cell populations identified on the basis of differ-
ent CD45RA, CD7, CD10, and CD19 expression (Haddad
et al., 2004). Only two of the populations, the CD34hi
CD45RAhiCD7+ and CD34hiCD45RAhiLin2CD10+ HPCs,
were found to display a significant capacity to generate
NK cells. Investigating their capacities to differentiate
into NK, B, and granulomonocytic cells at the single-
cell level showed then that the CD34hiCD45RAhiCD7+
HPCs were highly enriched in NK or mixed B/NK precur-
sors, whereas the CD34hiCD45RAhiLin2CD10+ HPCs
displayed a greater B potential. A third CD34+CD45RAint
Lin2 HPC population, used as a control for these exper-
iments, displayed a more immature profile, since a ma-
jority of NK, B, and myeloid clones were recovered
from individually seeded cells; however, these cells
had limited erythroid potential, indicating that they
were mixed granulomonocytic and lymphoid precur-
sors. Further analysis in FTOCs and OP9-DL1 cultures
confirmed that the T potential segregated indeed with
the CD34hiCD45RAhiCD7+ HPCs, indicating that they
are also enriched in T cell precursors. Gene expression
profiling with DNA microarrays validated the biological
phenotype of these cells by showing that
CD34+CD45RAhiCD7+ HPCs selectively expressed T
lymphoid and NK lineage-committed genes. As ex-
pected, the more immature CD34+CD45RAintLin2
HPCs displayed a stem-cell-like ‘‘signature’’ (Ivanova
et al., 2002).Having established that the CD34hiCD45RAhiCD7+
HPCs are endowed with strong T/NK potential, as re-
quested for candidate prethymocytes, we proceeded
to demonstrate that they could indeed correspond to
the so-called ‘‘thymus-colonizing cells.’’ To date, most
studies on early human lymphoid progenitors are based
on the in vitro assessment of their differentiation poten-
tials (Canque et al., 2000; Galy et al., 1995; Hao et al.,
2001). Because it is now recognized that disclosure of
an in vitro differentiation potential does not necessarily
correlate with a biological function, such an approach
does not allow one to draw firm conclusions as to the
precise physiological role of a given cell population. Al-
though in vivo xenogeneic mouse models such as NOD-
SCID mice have provided valuable insights into HSC/
HPC biology, they still are not usable to study early hu-
man lymphoid progenitors, which we found to lack en-
graftment capacity (R.H., F.P., and B.C., unpublished
data). To circumvent these limitations, we designed
a developmental approach to examine the contribution
to the T lineage ontogeny of the CD34hiCD45RAhiCD7+
HPCs. The criteria selected for identifying candidate fe-
tal prethymocytes were as follows: (1) they should be
detectable in extrathymic hematopoietic sites at the
early onset of thymus colonization as well as in the fetal
blood, (2) they should display a phenotype allowing the
establishment of a tight ontogenetic link with the most
immature fetal CD34hiCD1a2 thymocytes and parallel(B) CD34+CD45RAhiCD7+ seeded lobes were also analyzed by two-photon excitation microscopy; serial optic sections at high magnification
(original magnification 633) followed by three-dimensional projections are presented; side views represent transversal projections of the lobes.
Bars correspond to 20 mm.
(C) CD34+CD45RAintLin2 HPCs sorted from UCB were labeled with CFSE and cultured for 48 hr in hanging drops with or without SCF, IL-2, and
IL-7 before analysis by one-photon excitation confocal microscopy (original magnification 203).
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possess a strong T cell potential and display a selective
capacity to enter the thymus parenchyma in ex vivo col-
onization assays.
Precise in vivo tracking in human fetuses showed that
these HPCs emerge in the BM by gestation weeks 8–9,
at the very onset of its colonization by FL-derived
HSCs and that, in contrast to CD342CD7+CD56+ mature
NK cells and CD19+ BL precursors, which are detected
as early as week 6 among FL MNCs, they are virtually ab-
sent from this organ before the establishment of BM he-
matopoiesis. These results are consistent with reports
that the human FL does not provide an environment
permissive to the differentiation of TL precursors
(Blom et al., 1997; Jaleco et al., 1997). The bell curve
kinetics followed by CD34hiCD45RAhiCD7+ and
CD34+CD45RAhiLin2CD10+ HPCs in the fetal BM raises
important questions as to the developmental regulation
of early lymphoid progenitors during fetal life. Indeed, al-
though CD34+CD45RAhiLin2CD10+ cells persist at
higher levels in the postnatal BM (Rossi et al., 2003),
our data indicate that the two populations are coregu-
lated. These observations strongly argue for a previously
unrecognized role of the fetal BM in the generation of
lymphoid progenitors from gestation weeks 8 to 25,
i.e., as long as FL hematopoiesis remains active to sup-
port myelopoiesis. In this respect, it should also be
noted that the progressive decline of CD34hiCD45RAhi
CD7+ and CD34+CD45RAhiLin2CD10+ HPC frequency
in the BM during development third trimester coincides
with the cessation of FL hematopoiesis, when the BM
becomes the only site where HSCs reside and differen-
tiate. Like their UCB homologs (Haddad et al., 2004),
CD34hiCD45RAhiCD7+ HPCs from the fetal BM display
strong NK and T potentials together with a limited ca-
pacity to generate BLs, indicating the identity between
the two populations. However, due to limited cell num-
bers, the in vitro differentiation potential of BM cells
could not be tested prior to gestation week 12 and,
therefore, we cannot rule out that BM CD34hiCD45RAhi
CD7+ HPCs could then display a broader differentiation
potential. Also consistent with the report that, in the
mouse, the choice between T and B lineage commit-
ment precedes thymus entry (Harman et al., 2005) is
our observation that the CD34hiCD45RAhiCD7+ and
CD34hiCD45RAhiLin2CD10+ populations are both de-
tected in the fetal BM as the very onset of its coloniza-
tion by FL-derived HSCs.
Combining phenotypic, functional, and molecular cri-
teria, we also show that BM CD34hiCD45RAhiCD7+
HPCs are immediate upstream precursors of
CD34hiCD1a2 thymocytes, which display similar devel-
opmental kinetics during fetal as well as early postnatal
life. A key point is that our data fit the kinetics of fetal thy-
mus colonization, since CD34hiCD45RAhiCD7+ progeni-
tors are detected in both the BM and thymus as early as
gestation weeks 8–9 (Haynes and Heinly, 1995). When
assayed for in vitro differentiation potentials, the most
immature CD34hiCD1a2CD1272 thymocytes lacked
granulomonocytic potential while retaining a weak ca-
pacity to generate BLs (Sanchez et al., 1994; Terstappen
et al., 1992). These data are consistent with the fact that
these thymocytes also express surface CD2 and cyto-
plasmic CD3, indicating that specification toward the Tlineage starts as early as prethymocytes transmigrate
or extravasate from postcapillary veinules. Also consis-
tent with a recent murine report (Benz and Bleul, 2005),
we found that the immediate CD127+ progeny of the
CD34hiCD1a2CD1272 thymocytes lacks B potential
while retaining the capacity to generate both NK cells
and DCs. Histological analysis showed that early thymic
immigrants closely interact with dendritic-like pro-
cesses emanating from the TECs localized in the peri-
vascular sheaths. Rather than defining a putative ‘‘thy-
mic niche’’ where TL specification should take place,
our findings indicate that the crosstalk between early
thymic immigrants and TECs occurs through establish-
ment of structures resembling ‘‘lymphostromal synap-
ses’’ that probably drive rapid commitment toward the
T lineage. Finally, the observation that the earliest thy-
mic immigrants are scattered throughout the cortical
zone also argues for multifocal thymus seeding and con-
firms the previously documented differences between
fetal and postnatal thymus colonization (Kyewski,
1987; Le Douarin et al., 1984; Lind et al., 2001). Based
on these findings, we propose an updated model of fetal
TL ontogeny (Figure S7).
That BM-derived CD34hiCD45RAhiCD7+ HPCs actu-
ally correspond to thymus-seeding cells was confirmed
by an ex vivo thymus-colonization assay. Although such
assay might not reflect the real in vivo conditions of thy-
mus entry, it appears close enough and provides evi-
dence that, even without exogenously added cytokines,
these HPCs are specifically recruited into the thymus,
where they adopt a definitive TL fate. In fact, cytokines
were also found to stimulate CD34hiCD45RAintCD72
HPCs to acquire some capacity to invade the thymic
parenchyma but not to differentiate into TLs, and this
further indicates that a xenogeneic thymus microenvi-
ronment does not by itself allow efficient specification
toward the T lineage. These results strongly argue for
a two-step selection of thymus-colonizing cells at both
the entry and postentry levels and are in line with reports
that the extrathymic acquisition of T potential in mice
correlates with expression of surface receptors allowing
direct transmigration inside the thymus parenchyma (Liu
et al., 2005; Masuda et al., 2005). In conclusion, the pres-
ent results indicate that BM-derived CD34hiCD45RAhi
CD7+ precursors fit the criteria for fetal prethymocytes,
arguing thus for a generalized model of regulated thy-
mus colonization during fetal life.
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